ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Safety, Efficacy, and Cost Saving Potential of Various Weight-Based Dosing for Thymoglobulin Induction Therapy in Kidney Transplant Recipients.

    R. Miller,1 H. Meadows,1 S. Strout,1 T. Veasey,1 A. Mardis,1 J. Fleming,1 C. Mardis,1 N. Pilch,1 K. Chavin,2 D. Taber.2

    1Department of Pharmacy, Medical University of South Carolina, Charleston, SC; 2Department of Surgery, Medical University of South Carolina, Charleston, SC.

    Introduction: There are limited data assessing the appropriate weight to use when dosing Thymoglobulin for induction therapy. The aim of this study is to assess…
  • 2016 American Transplant Congress

    Virtual Crossmatching Under the New KAS: Safely Bypassing a Physical Crossmatch When Allocating Kidneys to Highly Sensitized Candidates.

    R. Bray,1 R. Parsons,2 N. Turgeon,2 H. Gebel.1

    1Pathology, Emory University, Atlanta, GA; 2Emory Transplant Center, Emory University, Atlanta, GA.

    AIM: On 12/4/2014, the OPTN implemented a new KAS for deceased donor(DD) transplants which, among many changes, increased priority for highly sensitized (HS) candidates (cPRA>98%).…
  • 2016 American Transplant Congress

    New Kidney Allocation System: Friend or Foe?

    F. Cabeza,2 A. Dejman,1 A. Torres,3 J. Gaynor,2 P. Ruiz,2 D. Roth,2 W. Kupin,2 G. Burke,2 G. Ciancio,2 L. Chen,2 R. Vianna,2 A. Mattiazzi,2 G. Guerra.2

    1Nephrology and Hypertension, University of Miami, Miami, FL; 2Kidney Transplant, Miami Transplant Institute, Miami, FL; 3Internal Medicine, Hospital San Jose Tec de Monterrey, Mexico D.F., Mexico.

    BACKGROUND The new kidney allocation (KAS) system was implemented 12/2014 to increase recipient life years gained annually and facilitate the transplantation of harder to match…
  • 2016 American Transplant Congress

    Reciprocal Effects of HDAC1 and HDAC2 Deletion on Renal Cold Ischemia Survival and Nuclear Co-Repressor Complex Expression.

    D. Aufhauser Jr,1 D. Murken,1 Z. Wang,1 A. Samanta,2 G. Ge,1 T. Bhatti,3 W. Hancock,2,3 M. Levine.1

    1Surgery, University of Pennsylvania, Philadelphia, PA; 2Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; 3Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA.

    Introduction: Class I histone/protein deacetylases (HDACs) 1 and 2 bear >85% protein sequence homology and conventionally are thought to have similar function via occupancy in…
  • 2016 American Transplant Congress

    Hydrogen Sulfide Treatment Mitigates Donor Tissue Necrosis During Prolonged Cold Storage and Improves Survival Following Allogeneic Renal Transplantation.

    I. Lobb,1,3 W. Liu,2 J. Jiang,3 D. Lian,3 A. Sener.1,3,4

    1Microbiology and Immunology, Western University Canada, London, ON, Canada; 2Pathology, Western University Canada, London, ON, Canada; 3Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, ON, Canada; 4Surgery, Western University Canada, London, ON, Canada.

    Organ procurement is inherently associated with ischemia-reperfusion injury (IRI), resulting from loss and subsequent restoration of blood flow, which is detrimental to short- and long-term…
  • 2016 American Transplant Congress

    Health Insurance Trends in United States Living Kidney Donors.

    J. Rodrigue,1,2 A. Fleishman.1

    1Surgery, Beth Israel Deaconess Medical Center, Boston, MA; 2Surgery, Harvard Medical School, Boston, MA.

    The aim of this study was to examine health insurance trends in living kidney donors (LKDs) in the United States and their association with donor…
  • 2016 American Transplant Congress

    A Pilot Study of Donor: A Smart Phone Application for Identifying Live Kidney and Liver Donors.

    K. Kumar,1 E. King,1 A. Muzaale,1 J. Konel,1 G. Segal,3 J. Arnold,3 K. Bramstedt,4 D. Segev,1,2 A. Cameron.1

    1Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; 2Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD; 3ORGANIZE, New York, NY; 4Bond University School of Medicine, Gold Coast, QLD, Australia.

    Background: With over 100,000 candidates waiting, rates of deceased donation stagnant, and only 17,000 Kidney and liver transplants a year, live donor transplantation may represent…
  • 2016 American Transplant Congress

    An Assurance of Insurance: Should Living Kidney Donors Be Required to Have Health Insurance?

    J. Siegel,1 A. Humar,2 P. Gianaros,1 J. Steel.2

    1Department of Psychology, University of Pittsburgh, Pittsburgh, PA; 2Department of Surgery, Division of Transplantation, University of Pittsburgh, Pittsburgh, PA.

    Lack of health insurance has been related lack of access to health care, poorer health, and increased mortality. In this study, we investigate sociodemographic predictors…
  • 2016 American Transplant Congress

    Associations of Perfusate Biomarkers and Pump Parameters with Delayed Graft Function and Deceased-Donor Kidney Allograft Function.

    C. Parikh,1 I. Hall,1 R. Bhangoo,2 J. Ficek,1 P. Abt,3 H. Thiessen-Philbrook,1 H. Lin,1 M. Bimali,1 P. Murray,4 V. Rao,1 B. Schröppel,5 M. Doshi,6 F. Weng,7 P. Reese.3

    1Yale University School of Medicine, New Haven, CT; 2University of Arizona College of Medicine, Phoenix, AZ; 3University of Pennsylvania, Philadelphia, PA; 4University College Dublin, Dublin, Ireland; 5Mount Sinai School of Medicine, New York, NY; 6Wayne State University, Detroit, MI; 7Barnabas Health, Livingston, NJ.

    Hypothermic machine perfusion (HMP) is increasingly used in deceased-donor kidney transplantation, but controversy exists regarding the value of perfusion biomarkers and pump parameters for assessing…
  • 2016 American Transplant Congress

    Don't Judge a Book by Its Cover: Normal Liver Enzymes After Transplantation Can Be Associated with Pathologies Requiring Intervention.

    C. Sanchez,1 S. Kumer,2 S. Olson,1 R. Gilroy,1 T. Schmitt,2 B. Kane,2 R. Taylor.1

    1Hepatology/Transplant, University of Kansas, Kansas City, KS; 2Surgery, University of Kansas, Kansas City, KS.

    Background:Liver biopsies are employed post-transplant generally to evaluate abnormal liver enzymes (LE); however they are not without risk. Whether post-transplant protocol biopsies (PB) serve any…
  • « Previous Page
  • 1
  • …
  • 140
  • 141
  • 142
  • 143
  • 144
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences